{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:06:13Z","timestamp":1793833573931,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancerf\u00f6reningen i Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["82103492"],"award-info":[{"award-number":["82103492"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The ETS transcription factor GABPA exhibits an oncogenic effect by activating telomerase in many cancers; however, some studies imply its tumor suppressive activities. It is thus important to define its different roles in oncogenesis. By examining GABPA-transgenic mice, we unexpectedly observed that Collagen I and III (Col I and III) contents were significantly reduced in murine dermis, which was accompanied by downregulation of prolyl 4-hydroxylase (P4HA2), an enzyme catalyzing collagen folding and fiber stabilization. In bladder cancer (BC) cells, GABPA similarly inhibited Col I and III formation, whereas Col levels increased upon GABPA depletion, revealing its modulation of extracellular matrix (ECM) deposition and stiffness. Mechanistically, GABPA induced miR-30e expression by stimulating <jats:italic>DICER1<\/jats:italic> transcription, and higher levels of miR-30e consequently targeted P4HA2 for its downregulation. Consistently, P4HA2 overexpression promoted Col formation, cell proliferation, and invasion, while its depletion or the specific P4HA2 inhibitor exerted opposite effects. In tumors derived from GABPA-overexpressed BC cells, atomic force microscope assessment showed that ECM rigidity was significantly reduced, coupled with diminished metastasis in xenografted mice, while P4HA2 overexpression led to stiffer ECM and increased metastasis, counteracting the GABPA effect. Moreover, GABPA knockdown or P4HA2 overexpression promoted YAP1 expression and its nuclear translocation, activating mechanotransduction signaling, through which accelerated proliferation and epithelial-mesenchymal transition occurred. Consistently, high miR-30e and P4HA2 expression were associated with favorable and unfavorable outcomes in BC patients, respectively. Collectively, GABPA inhibits P4HA2 expression and Col formation through the DICER1-miR30e axis, thereby repressing ECM deposition\/stiffness and blocking mechanotransduction signaling, which consequently restrains BC aggressiveness. These findings unravel a novel role for GABPA in BC pathogenesis and have biological and therapeutic implications.<\/jats:p>","DOI":"10.1038\/s41419-025-07935-z","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T17:16:41Z","timestamp":1755191801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The ETS transcription factor GABPA inhibits bladder cancer aggressiveness by repressing extracellular matrix deposition and mechanotransduction signaling"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0883-4979","authenticated-orcid":false,"given":"Mingkai","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6784-2638","authenticated-orcid":false,"given":"Feng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3141-4524","authenticated-orcid":false,"given":"Dawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"7935_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Science Transl Med. 2024;16:eadg3840.","journal-title":"Science Transl Med"},{"key":"7935_CR2","doi-asserted-by":"crossref","unstructured":"Nia HT, Munn LL, Jain RK. Physical traits of cancer. Science. 2020;370:eaaz0868.","DOI":"10.1126\/science.aaz0868"},{"key":"7935_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15:1243\u201353.","journal-title":"EMBO Rep"},{"key":"7935_CR4","doi-asserted-by":"crossref","unstructured":"Cruz-Acuna R, Kariuki SW, Sugiura K, Karaiskos S, Plaster EM, Loebel C et al. Engineered hydrogel reveals contribution of matrix mechanics to esophageal adenocarcinoma and identifies matrix-activated therapeutic targets. J Clin Invest. 2023;133:e168146.","DOI":"10.1172\/JCI168146"},{"key":"7935_CR5","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"7935_CR6","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315\u201322.","DOI":"10.1038\/nature12965"},{"key":"7935_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nature Rev Cancer. 2015;15:25\u201341.","journal-title":"Nature Rev Cancer"},{"key":"7935_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jare.2021.11.010","volume":"39","author":"S Liu","year":"2022","unstructured":"Liu S, Chen X, Lin T. Emerging strategies for the improvement of chemotherapy in bladder cancer: current knowledge and future perspectives. J Adv Res. 2022;39:187\u2013202.","journal-title":"J Adv Res"},{"key":"7935_CR9","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1172\/JCI139597","volume":"130","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang J, Ruan W, Huang M, Wang C, Wang H, et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Invest. 2020;130:6278\u201389.","journal-title":"J Clin Invest"},{"key":"7935_CR10","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/s41418-019-0466-7","volume":"27","author":"Y Guo","year":"2020","unstructured":"Guo Y, Yuan X, Li K, Dai M, Zhang L, Wu Y, et al. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer. Cell Death Differ. 2020;27:1862\u201377.","journal-title":"Cell Death Differ"},{"key":"7935_CR11","first-page":"404","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70:404\u201323.","journal-title":"CA Cancer J Clin"},{"key":"7935_CR12","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer JS, Hoadley KA, Chism DD, Fan C, Tiganelli CJ, Wobker SE, et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci USA. 2014;111:3110\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7935_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25:152\u201365.","journal-title":"Cancer Cell"},{"key":"7935_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/path.4886","volume":"242","author":"G Sjodahl","year":"2017","unstructured":"Sjodahl G, Eriksson P, Liedberg F, Hoglund M. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification. J. Pathol. 2017;242:113\u201325.","journal-title":"J. Pathol"},{"key":"7935_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.euo.2023.07.011","volume":"7","author":"M Eckstein","year":"2024","unstructured":"Eckstein M, Matek C, Wagner P, Erber R, Buttner-Herold M, Wild PJ, et al. Proposal for a novel histological scoring system as a potential grading approach for muscle-invasive urothelial bladder cancer correlating with disease aggressiveness and patient outcomes. Eur Urol Oncol. 2024;7:128\u201338.","journal-title":"Eur Urol Oncol"},{"key":"7935_CR16","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1158\/0008-5472.CAN-20-2336","volume":"81","author":"A Wullweber","year":"2021","unstructured":"Wullweber A, Strick R, Lange F, Sikic D, Taubert H, Wach S, et al. Bladder tumor subtype commitment occurs in carcinoma in situ driven by key signaling pathways including ECM remodeling. Cancer Res. 2021;81:1552\u201366.","journal-title":"Cancer Res"},{"key":"7935_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/nyas.14358","volume":"1473","author":"H Ghasemi","year":"2020","unstructured":"Ghasemi H, Mousavibahar SH, Hashemnia M, Karimi J, Khodadadi I, Mirzaei F, et al. Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection. Ann N Y Acad Sci. 2020;1473:48\u201361.","journal-title":"Ann N Y Acad Sci"},{"key":"7935_CR18","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","volume":"38","author":"X Yuan","year":"2019","unstructured":"Yuan X, Larsson C, Xu D. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players. Oncogene. 2019;38:6172\u201383.","journal-title":"Oncogene"},{"key":"7935_CR19","doi-asserted-by":"publisher","first-page":"19542","DOI":"10.18632\/oncotarget.4295","volume":"6","author":"C Li","year":"2015","unstructured":"Li C, Wu S, Wang H, Bi X, Yang Z, Du Y, et al. The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer. Oncotarget. 2015;6:19542\u201351.","journal-title":"Oncotarget"},{"key":"7935_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.07.003","volume":"493","author":"X Yuan","year":"2020","unstructured":"Yuan X, Dai M, Xu D. TERT promoter mutations and GABP transcription factors in carcinogenesis: more foes than friends. Cancer Lett. 2020;493:1\u20139.","journal-title":"Cancer Lett"},{"key":"7935_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.eururo.2013.08.057","volume":"65","author":"CD Hurst","year":"2014","unstructured":"Hurst CD, Platt FM, Knowles MA. Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. European Urol. 2014;65:367\u20139.","journal-title":"European Urol"},{"key":"7935_CR22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.aab0015","volume":"348","author":"RJ Bell","year":"2015","unstructured":"Bell RJ, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP, et al. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science. 2015;348:1036\u20139.","journal-title":"Science"},{"key":"7935_CR23","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jid.2018.10.038","volume":"139","author":"A Atkinson","year":"2019","unstructured":"Atkinson A, Renziehausen A, Wang H, Lo Nigro C, Lattanzio L, Merlano M, et al. Collagen prolyl hydroxylases are bifunctional growth regulators in melanoma. J Invest Dermatol. 2019;139:1118\u201326.","journal-title":"J Invest Dermatol"},{"key":"7935_CR24","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41418-023-01156-7","volume":"30","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Mukherjee A, Pisano S, Dimri S, Knaane E, Altshuler A, et al. The biophysical property of the limbal niche maintains stemness through YAP. Cell Death Differ. 2023;30:1601\u201314.","journal-title":"Cell Death Differ"},{"key":"7935_CR25","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","volume":"154","author":"M Aragona","year":"2013","unstructured":"Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, et al. A mechanical checkpoint controls multicellular growth through YAP\/TAZ regulation by actin-processing factors. Cell. 2013;154:1047\u201359.","journal-title":"Cell"},{"key":"7935_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474:179\u201383.","journal-title":"Nature"},{"key":"7935_CR27","doi-asserted-by":"crossref","unstructured":"Ishihara S, Kurosawa H, Haga H. Stiffness-modulation of collagen gels by genipin-crosslinking for cell culture. Gels. 2023;9:148.","DOI":"10.3390\/gels9020148"},{"key":"7935_CR28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41388-018-0483-x","volume":"38","author":"X Yuan","year":"2019","unstructured":"Yuan X, Mu N, Wang N, Straat K, Sofiadis A, Guo Y, et al. GABPA inhibits invasion\/metastasis in papillary thyroid carcinoma by regulating DICER1 expression. Oncogene. 2019;38:965\u201379.","journal-title":"Oncogene"},{"key":"7935_CR29","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1038\/onc.2017.291","volume":"36","author":"GX Feng","year":"2017","unstructured":"Feng GX, Li J, Yang Z, Zhang SQ, Liu YX, Zhang WY, et al. Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA. Oncogene. 2017;36:6895\u2013905.","journal-title":"Oncogene"},{"key":"7935_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205613","volume":"10","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Liu S, Wang H, Xiao K, Lu J, Chen S, et al. ETV4 mediated tumor-associated neutrophil infiltration facilitates lymphangiogenesis and lymphatic metastasis of bladder cancer. Adv Sci. 2023;10:e2205613.","journal-title":"Adv Sci"},{"key":"7935_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1140891","volume":"13","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Li X, Liu D, Li Z. A novel signature of aging-related genes associated with lymphatic metastasis for survival prediction in patients with bladder cancer. Front Oncol. 2023;13:1140891.","journal-title":"Front Oncol"},{"key":"7935_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/cac2.12284","volume":"42","author":"M Huang","year":"2022","unstructured":"Huang M, Dong W, Xie R, Wu J, Su Q, Li W, et al. HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program. Cancer Commun. 2022;42:447\u201370.","journal-title":"Cancer Commun"},{"key":"7935_CR33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/s41416-023-02383-y","volume":"129","author":"J Lu","year":"2023","unstructured":"Lu J, Lai J, Xiao K, Peng S, Zhang Y, Xia Q, et al. A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort study. Br J Cancer. 2023;129:1166\u201375.","journal-title":"Br J Cancer"},{"key":"7935_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05938-2","volume":"14","author":"K Xiao","year":"2023","unstructured":"Xiao K, Peng S, Lu J, Zhou T, Hong X, Chen S, et al. UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer. Cell Death Dis. 2023;14:408.","journal-title":"Cell Death Dis"},{"key":"7935_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02992-w","volume":"23","author":"S Safaei","year":"2023","unstructured":"Safaei S, Sajed R, Shariftabrizi A, Dorafshan S, Saeednejad Zanjani L, Dehghan Manshadi M, et al. Tumor matrix stiffness provides fertile soil for cancer stem cells. Cancer Cell Int. 2023;23:143.","journal-title":"Cancer Cell Int"},{"key":"7935_CR36","doi-asserted-by":"crossref","unstructured":"Nilsson MB, Sun H, Robichaux J, Pfeifer M, McDermott U, Travers J, et al. A YAP\/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components. Sci Transl Med. 2020;12:eaaz4589.","DOI":"10.1126\/scitranslmed.aaz4589"},{"key":"7935_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/ERC-19-0446","volume":"27","author":"JO Paulsson","year":"2020","unstructured":"Paulsson JO, Wang N, Gao J, Stenman A, Zedenius J, Mu N, et al. GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours. Endocr Relat Cancer. 2020;27:295\u2013308.","journal-title":"Endocr Relat Cancer"},{"key":"7935_CR38","doi-asserted-by":"crossref","unstructured":"Long M, Zhu Y, Chen Z, Lin S, Peng X, Luo D, et al. Lysine-specific demethylase 1 affects the progression of papillary thyroid carcinoma via HIF1alpha and microRNA-146a. J Clin Endocrinol Metab. 2020;105:dgaa182.","DOI":"10.1210\/clinem\/dgaa182"},{"key":"7935_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.98","volume":"3","author":"A Nigro","year":"2012","unstructured":"Nigro A, Menon R, Bergamaschi A, Clovis YM, Baldi A, Ehrmann M, et al. MiR-30e and miR-181d control radial glia cell proliferation via HtrA1 modulation. Cell Death Dis. 2012;3:e360.","journal-title":"Cell Death Dis"},{"key":"7935_CR40","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-17-3058","volume":"78","author":"M Croset","year":"2018","unstructured":"Croset M, Pantano F, Kan CWS, Bonnelye E, Descotes F, Alix-Panabieres C, et al. miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes. Cancer Res. 2018;78:5259\u201373.","journal-title":"Cancer Res"},{"key":"7935_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-022-02382-6","volume":"41","author":"Z Fang","year":"2022","unstructured":"Fang Z, Zhang N, Yuan X, Xing X, Li X, Qin X, et al. GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma. J Exp Clin Cancer Res. 2022;41:173.","journal-title":"J Exp Clin Cancer Res"},{"key":"7935_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1634\/theoncologist.2014-0391","volume":"20","author":"K Wang","year":"2015","unstructured":"Wang K, Liu T, Liu C, Meng Y, Yuan X, Liu L, et al. TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer. Oncologist. 2015;20:263\u20139.","journal-title":"Oncologist"},{"key":"7935_CR43","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.7150\/jca.56779","volume":"12","author":"X Xing","year":"2021","unstructured":"Xing X, Yuan X, Liu T, Dai M, Fan Y, Liu C, et al. Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas. J Cancer. 2021;12:3853\u201361.","journal-title":"J Cancer"},{"key":"7935_CR44","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201247R","volume":"37","author":"X Li","year":"2023","unstructured":"Li X, Li Y, Liu B, Chen L, Lyu F, Zhang P, et al. P4HA2-mediated HIF-1alpha stabilization promotes erdafitinib-resistance in FGFR3-alteration bladder cancer. FASEB J. 2023;37:e22840.","journal-title":"FASEB J"},{"key":"7935_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ebiom.2019.06.048","volume":"45","author":"T Wang","year":"2019","unstructured":"Wang T, Fu X, Jin T, Zhang L, Liu B, Wu Y, et al. Aspirin targets P4HA2 through inhibiting NF-kappaB and LMCD1-AS1\/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma. EBioMedicine. 2019;45:168\u201380.","journal-title":"EBioMedicine"},{"key":"7935_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ncb1548","volume":"9","author":"ZF Yang","year":"2007","unstructured":"Yang ZF, Mott S, Rosmarin AG. The Ets transcription factor GABP is required for cell-cycle progression. Nat Cell Biol. 2007;9:339\u201346.","journal-title":"Nat Cell Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07935-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:54:46Z","timestamp":1757483686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07935-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7935"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07935-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Shandong University 2nd Hospital and the Shandong Provincial Hospital Ethics Committees. Informed consent was obtained from all the patients. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"618"}}